Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 31

1.
2.

Vaccination against cytomegalovirus.

Plotkin SA.

Arch Virol Suppl. 2001;(17):121-34. Review.

PMID:
11339541
3.

The next generation recombinant human cytomegalovirus vaccine candidates-beyond gB.

Lilja AE, Mason PW.

Vaccine. 2012 Nov 19;30(49):6980-90. doi: 10.1016/j.vaccine.2012.09.056. Epub 2012 Oct 3. Review.

PMID:
23041121
4.

Development of a cytomegalovirus vaccine: lessons from recent clinical trials.

Gonczol E, Plotkin S.

Expert Opin Biol Ther. 2001 May;1(3):401-12. Review.

PMID:
11727514
5.

Genomic variants among human cytomegalovirus (HCMV) clinical isolates: the glycoprotein n (gN) paradigm.

Dal Monte P, Pignatelli S, Rossini G, Landini MP.

Hum Immunol. 2004 May;65(5):387-94. Review.

PMID:
15172436
6.

Human cytomegalovirus glycoproteins.

Britt WJ, Mach M.

Intervirology. 1996;39(5-6):401-12. Review.

PMID:
9130049
7.

Prospects for the clinical management of human cytomegalovirus infections.

Farrar GH, Bull JR, Greenaway PJ.

Vaccine. 1986 Dec;4(4):217-24. Review.

PMID:
3026105
8.

Update on the current status of cytomegalovirus vaccines.

Sung H, Schleiss MR.

Expert Rev Vaccines. 2010 Nov;9(11):1303-14. doi: 10.1586/erv.10.125. Review.

9.

Vaccines for viral and parasitic diseases produced with baculovirus vectors.

van Oers MM.

Adv Virus Res. 2006;68:193-253. Review.

PMID:
16997013
10.

Cytomegalovirus vaccine.

Plotkin SA.

Am Heart J. 1999 Nov;138(5 Pt 2):S484-7. Review.

PMID:
10539854
11.

Progress on pursuit of human cytomegalovirus vaccines for prevention of congenital infection and disease.

Fu TM, An Z, Wang D.

Vaccine. 2014 May 7;32(22):2525-33. doi: 10.1016/j.vaccine.2014.03.057. Epub 2014 Mar 28. Review.

PMID:
24681264
12.
14.

A stress protein-facilitated antigen expression system for plasmid DNA vaccines.

Riedl P, Fissolo N, Reimann J, Schirmbeck R.

Methods Mol Med. 2006;127:41-53. Review.

PMID:
16988445
15.
16.

[Neutralizing human antibody specific for human cytomegalovirus in E. coli expression system].

Ihara S, Maeda F, Takekoshi M.

Nihon Rinsho. 1998 Jan;56(1):161-6. Review. Japanese.

PMID:
9465683
17.

DNA-designed avian IgY antibodies: novel tools for research, diagnostics and therapy.

Cova L.

J Clin Virol. 2005 Dec;34 Suppl 1:S70-4. Review.

PMID:
16461227
18.

A recombinant subunit vaccine approach to HCMV vaccine development.

Spaete RR.

Transplant Proc. 1991 Jun;23(3 Suppl 3):90-6. Review. No abstract available.

PMID:
1648843
19.

Cytomegalovirus Vaccines: Current Status and Future Prospects.

Anderholm KM, Bierle CJ, Schleiss MR.

Drugs. 2016 Nov;76(17):1625-1645. Review.

PMID:
27882457
20.

[DNA--the future in vaccine technology?].

Kjeken R, Bogen B, Mathiesen I.

Tidsskr Nor Laegeforen. 2006 Nov 16;126(22):2964-8. Review. Norwegian.

Supplemental Content

Support Center